Login
Password
Remember Me
Feedback form for experts
І. General information
5. Consequence of adverse reaction / lack of efficacy
8. Description of the adverse reaction / Indications of the lack of efficacy of the medicinal product (including the data of laboratory and instrumental studies concerning the adverse reaction)
9. Category of adverse reaction / lack of efficacy
ІІ. Information on suspected drug (SD), SD manufacturer
ІІІ. Information on concomitant drugs (with the exception of drugs that have been used to correct the effects of adverse reactions)
19. Concomitant drugs (trade name, dosage form, manufacturer)
26. Other important information (diagnoses, allergies, pregnancy with duration, etc.)
ІV. Means of correction of an adverse reaction
Was the SD canceled with the disappearance of adverse reaction?
Has the resumption of an adverse reaction been noted after re-appointment of the SD?
Has an update of the adverse reaction been noted after dosing SD?
V. Information about the notifier
28. Notification provides
29. The name and location of the health care institution or the applicant of the disease / ambulatory card
30. Source of notification (paragraph 30-32 only for the applicant)
33. Type of notification
Thank you
Your card has been successfully sent.
Registration
* - filling is mandatory
Error
Incorrect username or password.
Forgot your password?
Sign in
An error occurred while querying the server. Try later.
Attention
You go to the section of the Nikopharm website, which is intended for use by specialists in the field of medicine and pharmacy.
Do you confirm that you are a certified specialist?
Your question has been successfully submitted to the moderator for review.
The answer will come to you in the mail within 24 hours.